TSA seeks comment on cargo screening; Guardian's hypertension drug in short supply;

> The U.S. Transportation Security Administration seeks comment on plans for 100 percent cargo screening for inbound international aircraft. Story

> The FDA has added Guardian Labs' urologic irrigation solution Renacidin to its list of drugs in short supply. Listing

> Counterfeits-fighter Sproxil is one of several companies that will benefit from a $150 million investment by IBM in the White House-led Startup America campaign for entrepreneurs. IBM release

> A Chinese national pleaded guilty earlier this week to charges of trafficking and attempting to traffic a counterfeit version of the weight-loss drug Alli. Story

> Ohio's new execution drug could be just as problematic as the last one. Story

> In a sign of biopharma manufacturing's restructuring, Amgen and Sanofi-Aventis plan to sell manufacturing facilities to contract manufacturers. Article

> West Pharmaceutical has named Jeffrey Hunt president of the pharmaceutical packaging systems business. West release

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.